Personal genomics is the branch of science giving insight into human metabolism and disease strains based on individual genetic traits with familial genetics playing a contributory role. Segmentation of digital genome market by Component Type comprises hardware, software and services. Digital genomics is an extension to personal genomics banking on intensive study data collated by research and co-relating this factual representation with published literature.
The global digital genome market is driven by increase in chronic diseases, global rise in geriatric population, demand for accuracy in diagnosis and treatment of diseases using digital genome techniques and applications, increased research in genomics, and rise in funding related to digitalization. On February 8, 2016, the National Human Genome Research Institute proposed its novel initiative named Genes, Environment, and Health Initiative (GEI). The aim of this project is to assist the research and development related to better understanding of the genetic contribution and their role in the development of diseases. Funding by government agencies is one of the major drivers of the global digital genome market. For example, the Genomics R&D Initiative (GRDI) based in Canada cooperates with other federal science departments and agencies in the development of genomic research. On the other hand, high costs related with the use of digital genome techniques and products, less awareness about digital genome in developing economies, and side effects related to use of new product are factors anticipated to hamper market growth.

Market Analysis and Insights: Global Digital Genome Market
The global Digital Genome market size is projected to reach US$ 10930 million by 2027, from US$ 6963.3 million in 2020, at a CAGR of 6.2% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Digital Genome market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Digital Genome market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Digital Genome market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Digital Genome market.

Global Digital Genome Scope and Market Size
Digital Genome market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Digital Genome market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Sequencing Services
Sequencing Instruments
Sequencing Consumables
Bioinformatics
Sample Preparation Kits and Reagents

Segment by Application
Diagnostics
Agriculture & Animal Research
Personalized Medicine
Drug Discovery
Treatment Analysis

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Umbel
NanoString
BiogeniQ
GenomeMe
Illumina